NCT05709210 · RECRUITING
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
This pilot study tracks how people with memory complaints, mild cognitive decline, or Alzheimer's disease actually use their smartphones day to day. Researchers want to know whether those usage patterns differ enough across the three groups to serve as a potential diagnostic signal. It is a Phase NA feasibility study, meaning the goal right now is simply to test whether this approach is practical and worth pursuing further, not to prove any treatment works.
You may qualify if
- Patient consulting in routine care in one of the CMRR
- No sensory impairment that may compromise smartphone use
You're excluded if
- Inability to perform MMSE or MMSE \< 20 ;
- Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
- Severe anxiety or depressive disorder HADS score ≥ 17
- Terminal phase of a severe disease
- Evidence of a lesion on MRI that may be involved in cognitive impairment
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-03-11